Myungmoon Pharm Co Ltd (017180) Stock Price & News

Why is 017180 up 4.72%?

Dive Deeper

017180:KRX

Myungmoon Pharm Co Ltd

₩1,309.00

+4.72%

(+59.00) 1D

Oct 16, 3:30:30 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 017180...

Open

₩1,285

High

₩1,323

Low

₩1,259

Mkt. cap

44.45B

Avg. vol.

300.34K

Volume

0.00

52-wk high

₩2,055

52-wk low

₩1,000

EPS

-₩49

Shares outstanding

33.95M

No. of employees

319

Open

₩1,285

High

₩1,323

Low

₩1,259

Mkt. cap

44.45B

Avg. vol.

300.34K

Volume

0.00

52-wk high

₩2,055

52-wk low

₩1,000

EPS

-₩49

Shares outstanding

33.95M

No. of employees

319

Related stocks

005500

Samjin Pharmaceutical Co Ltd

News stories

From web sources and news partners

KuCoin

1 hour ago

The Nasdaq fell 4.5% this week, its worst week since late Ju

Yahoo Finance UK

8 hours ago

Yardeni Lowers S&P 500 Target to 7,900 Despite Maintaining 2027 Earnings Forecast

The Motley Fool

4 hours ago

Should You Invest in the S&P 500 Right Now or Wait? There's 1 Clear Answer

Moomoo

1 day ago

There Is a Silent Market Rotation Inside the S&P 500 That's Warning of More Weakness Ahead

About Myungmoon Pharm Co Ltd

CEO-

Employees319

Founded1983

Headquarters-

SectorPharmaceutical industry

Websitemmpharm.co.kr

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	49.86B	50.75B	48.00B	51.21B
Cost of goods sold	23.26B	22.49B	21.26B	21.82B
Cost of revenue	23.26B	22.49B	21.26B	21.82B
Research and development expenses	1.20B	1.24B	764.90M	904.50M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	24.35B	25.30B	25.43B	29.00B
Operating expense	26.15B	26.65B	26.44B	30.23B
Total operating expenses	49.41B	49.14B	47.71B	52.05B
Operating income	453.76M	1.61B	293.53M	-836.37M
Other non operating income	374.15M	107.00M	1.08M	207.74M
EBT including unusual items	-377.34M	477.71M	-931.61M	-1.53B
EBT excluding unusual items	-413.37M	451.92M	-933.44M	-1.52B
Income tax expense	290.58M	-350.59M	104.15M	159.64M
Effective tax rate	-77.01%	-73.39%	-11.18%	-10.43%
Other operating expenses	513.85M	323.27M	334.38M	459.74M
Net income	-548.97M	943.18M	-801.77M	-1.26B
Net profit margin	-1.10%	1.86%	-1.67%	-2.46%
Earnings per share	-	-	-	-
Interest and investment income	12.20M	149.26K	7.57M	9.59M
Interest expense	-1.27B	-1.28B	-1.25B	-910.05M
Net interest expenses	-1.26B	-1.28B	-1.24B	-900.46M
Depreciation and amortization charges	175.00M	181.03M	176.03M	178.64M
EBITDA	1.47B	2.60B	1.26B	142.52M
Gain or loss from assets sale	6.73M	-22.85M	-3.00M	7.00K

Ask anything